– USA, CA – Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements, and medical devices, today announced the appointment of a seasoned healthcare executive, Michaela Griggs to its Board of Directors.
“We are very excited to welcome Michaela to our Board of Directors. Her marketing acumen and deep experience in both the consumer-driven and healthcare professional-driven markets make her an excellent addition to our already strong Board of Directors. Ms. Griggs nomination was extensively vetted by the Board’s newly formed Nominating and Corporate Governance Committee, which identified Michaela’s success and experience in the healthcare industry as being of tremendous value to the Company as we implement our growth strategies and our Environmental, Social and Governance initiatives,” said Board Chairman, Robert Weingarten.
“Michaela brings a wealth of knowledge and successful experience in product development and brand marketing that will provide tremendous value to our Company as we focus on our brand strategies and growth initiatives. We believe that having someone of Michaela’s caliber on our Board will accelerate the growth of our business and improve our operational efficiencies.” said CEO, Bret Scholtes.
About Michaela Griggs
Ms. Griggs currently serves as CEO of Los Angeles-based Southern California Reproductive Center. From 2017 through 2020, Ms. Griggs served as EVP at Barco Uniforms’ Health Care & Identity Divisions. For nearly 20 years before Barco, Ms. Griggs held key executive marketing positions at Allergan, Bayer Healthcare, 3M Unitek, and Tria Beauty, where she was instrumental in developing and improving brand, retail, and distribution strategies for global brands such as Botox, Juvederm, and One-A-Day® multi-vitamins, as well as other key brand portfolios.
“Guardian has incredible potential to be a leader in the nutrition market, with a clear focus on clinically-proven products aimed at specific markets and conditions. I believe that the recent acquisition of the Viactiv brand of products provides Guardion with significant marketing and growth opportunities. I look forward to helping Guardion achieve its objective of growth from both its existing product portfolio and from launching new, compelling and successful products,” said Ms. Griggs.
Ms. Griggs earned a Master’s in Business Administration degree from the London School of Business and Finance/the University of Wales, and her Diploma of the British Orthoptic Society from Sheffield/Leeds School of Orthoptics.
About Guardion Health Sciences, Inc.
Guardion Health Sciences, Inc. is a clinical nutrition and diagnostics company. Guardion’s portfolio of science-based, clinically supported nutrition, medical foods, and diagnostic products support healthcare professionals, their patients, and consumers in achieving health goals. Guardion’s commercial and developmental initiatives are supported by equally impressive scientific and medical advisory boards, led by seasoned business executives and physicians with many years of experience. This combination of expertise and scientific knowledge forms the foundation of Guardion’s growing position within the clinical nutrition marketplace. Information and risk factors concerning Guardion and its business, including its ability to successfully develop and commercialize its proprietary products and technologies, may be obtained in the Company’s filings with the U.S.
For more information: https://guardionhealth.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
